Positive TLR4 or PTK2 expression was accompanied by incomplete tumor encapsulation, microvascular invasion, poor differentiation, advanced TNM stage, poor OS, and high recurrence rates in our cohorts (Figure 3C-D, Table S4, S5). The gene discussed is TLR4; the disease is neoplasm.